These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30948237)

  • 1. Evaluation of the need for a fracture liaison service in a patient-centered medical home.
    Crissman JK; Woodall T; LaVallee L; Masterson J; Clouse L; Galvin SL; Scott MA
    J Am Pharm Assoc (2003); 2019; 59(4):565-569. PubMed ID: 30948237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of osteoporosis screening and treatment following vertebral fracture.
    Barton DW; Behrend CJ; Carmouche JJ
    Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Gupta MJ; Shah S; Peterson S; Baim S
    Osteoporos Int; 2018 Aug; 29(8):1861-1874. PubMed ID: 29869038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.
    Fojas MC; Southerland LT; Phieffer LS; Stephens JA; Srivastava T; Ing SW
    Arch Osteoporos; 2017 Dec; 12(1):16. PubMed ID: 28155141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
    Pflimlin A; Gournay A; Delabrière I; Chantelot C; Puisieux F; Cortet B; Paccou J
    Osteoporos Int; 2019 Sep; 30(9):1779-1788. PubMed ID: 31190123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing fracture prevention: the fracture liaison service, an observational study.
    Eekman DA; van Helden SH; Huisman AM; Verhaar HJ; Bultink IE; Geusens PP; Lips P; Lems WF
    Osteoporos Int; 2014 Feb; 25(2):701-9. PubMed ID: 24030287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic Fragility Fractures: An Opportunity to Improve the Undertreatment of Osteoporosis.
    Smith CT; Barton DW; Piple AS; Carmouche JJ
    J Bone Joint Surg Am; 2021 Feb; 103(3):213-218. PubMed ID: 33269895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
    Antonelli M; Einstadter D; Magrey M
    J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, study design, and descriptive data of the Lucky Bone™ Fracture Liaison Service.
    Senay A; Perreault S; Delisle J; Morin SN; Raynauld JP; Banica A; Troyanov Y; Beaumont P; Jodoin A; Laflamme GY; Leduc S; Mac-Thiong JM; Nguyen H; Ranger P; Rouleau DM; Fernandes JC
    Arch Osteoporos; 2019 Feb; 14(1):19. PubMed ID: 30756193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.
    Yates CJ; Chauchard MA; Liew D; Bucknill A; Wark JD
    J Clin Densitom; 2015; 18(2):150-6. PubMed ID: 25797867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
    Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
    Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study.
    Senay A; Fernandes JC; Delisle J; Morin SN; Perreault S
    Arch Osteoporos; 2019 Aug; 14(1):87. PubMed ID: 31375983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach.
    Olenginski TP; Maloney-Saxon G; Matzko CK; Mackiewicz K; Kirchner HL; Bengier A; Newman ED
    Osteoporos Int; 2015 Feb; 26(2):801-10. PubMed ID: 25398432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
    Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
    Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Greenspan SL; Singer A; Vujevich K; Marchand B; Thompson DA; Hsu YJ; Vaidya D; Stern LS; Zeldow D; Lee DB; Karp S; Recker R
    Osteoporos Int; 2018 Apr; 29(4):953-960. PubMed ID: 29429033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a 12-month analysis.
    Inderjeeth CA; Raymond WD; Briggs AM; Geelhoed E; Oldham D; Mountain D
    Osteoporos Int; 2018 Aug; 29(8):1759-1770. PubMed ID: 29704027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
    Fan W; Machado M; Leder BZ; Beyer L; Garcia EF; Kronenberg HM; Cevallos S; Espinoza J; Finkelstein JS; Bolster MB
    J Clin Endocrinol Metab; 2022 Dec; 108(1):191-197. PubMed ID: 36056816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Dunn P; Webb D; Olenginski TP
    Osteoporos Int; 2018 Feb; 29(2):451-457. PubMed ID: 29063214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.